Philadelphia Business JournalSpark Therapeutics signs gene therapy deal with French nonprofitPhiladelphia Business JournalSpark Therapeutics said Wednesday it has entered into a licensing agreement with Genethon for the development and commercializatio… Continue reading
R & D Magazine |
Researchers Investigate New Ways to Keep Stem Cells Alive
R & D Magazine New treatments have emerged to temporarily prevent stem cells from dying during hematopoietic stem cell (HSCs) transplants. Researchers from the University Medical Center of Freiburg in Germany have taken a new approach to allow those needing … |
|
FDA commissioner calls approval of first US cancer gene therapy ‘a significant milestone’
Pharmacy Today, American Pharmacists Association, pharmacist.com Noting FDA’s recent approval of CAR T-cell gene therapy, Gottlieb said in an interview, “This was the first approval in the United States and it was the first approval of a product that looks to be highly effective. … I think we’ve finally reached an … |
BioPharma-Reporter.com |
International Stem Cell Corporation to Move Forward with Traumatic Brain Injury Phase II Clinical Trial
GlobeNewswire (press release) 20, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and … US FDA stem cell enforcement challenged by state legislationBioPharma-Reporter.com Defining the Future of the Stem Cell Market and Exclusive Interviews with Stem Cell Industry Executives in 2017 ReportMedgadget (blog) Embryonic Stem Cell Research Still Hasn’t Cured a Single PatientLifeNews.com PR Web (press release) –Baystreet.ca –The Global Health News (press release) (blog) all 26 news articles » |
BioPharma-Reporter.com |
US FDA stem cell enforcement challenged by state legislation
BioPharma-Reporter.com Last month , for example, it sent a warning letter to a Sunrise, Florida-based clinic for marketing autologous stem cell products without FDA approval, and – with the help of the US Marshals Service – seized material for an unapproved stem cell product … ImStem, UConn Obtain US Patent for Mesenchymal Stem Cell Technology to Treat MS, Other DiseasesMultiple Sclerosis News Today “Stem Cell Therapy: A Rising Tide – How Stem Cells are Disrupting Medicine and Transforming Lives” – A New Book by …PR Web (press release) Stem Cell Assay Market Analysis, Segments, Growth and Value Chain 2016-2021Medgadget (blog) Business Wire (press release) –WhaTech –Reporter Day: Daily News Updates by Market.Biz all 17 news articles » |